FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 162 filers reported holding FIBROGEN INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,358 | +1.2% | 293,612 | +216.6% | 0.00% | 0.0% |
| Q2 2023 | $250,368 | -75.3% | 92,729 | +70.6% | 0.00% | -80.0% |
| Q1 2023 | $1,014,134 | -31.6% | 54,348 | -41.3% | 0.01% | -37.5% |
| Q4 2022 | $1,482,523 | +36.4% | 92,542 | +10.7% | 0.01% | +33.3% |
| Q3 2022 | $1,087,000 | +55.7% | 83,568 | +26.5% | 0.01% | +50.0% |
| Q2 2022 | $698,000 | -12.3% | 66,056 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $796,000 | -18.4% | 66,253 | -4.2% | 0.00% | -20.0% |
| Q4 2021 | $975,000 | +62.8% | 69,170 | +17.9% | 0.01% | +66.7% |
| Q3 2021 | $599,000 | -40.9% | 58,649 | +54.0% | 0.00% | -50.0% |
| Q2 2021 | $1,014,000 | -23.4% | 38,079 | -0.2% | 0.01% | -25.0% |
| Q1 2021 | $1,324,000 | +3.4% | 38,148 | +10.4% | 0.01% | 0.0% |
| Q4 2020 | $1,281,000 | +20.1% | 34,543 | +33.1% | 0.01% | 0.0% |
| Q3 2020 | $1,067,000 | +182.3% | 25,959 | +178.4% | 0.01% | +166.7% |
| Q2 2020 | $378,000 | +72.6% | 9,324 | +48.3% | 0.00% | +50.0% |
| Q1 2020 | $219,000 | -2.7% | 6,288 | +19.8% | 0.00% | 0.0% |
| Q4 2019 | $225,000 | +28.6% | 5,249 | +11.1% | 0.00% | +100.0% |
| Q3 2019 | $175,000 | -10.7% | 4,726 | +8.7% | 0.00% | -50.0% |
| Q2 2019 | $196,000 | -16.9% | 4,348 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $236,000 | -2.9% | 4,348 | -17.3% | 0.00% | 0.0% |
| Q4 2018 | $243,000 | -13.8% | 5,259 | +13.1% | 0.00% | 0.0% |
| Q3 2018 | $282,000 | 0.0% | 4,650 | +3.3% | 0.00% | -33.3% |
| Q2 2018 | $282,000 | +57.5% | 4,503 | +16.0% | 0.00% | +50.0% |
| Q1 2018 | $179,000 | -2.7% | 3,883 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $184,000 | +25.2% | 3,883 | +41.9% | 0.00% | +100.0% |
| Q3 2017 | $147,000 | +133.3% | 2,736 | +39.7% | 0.00% | 0.0% |
| Q2 2017 | $63,000 | +61.5% | 1,959 | +24.8% | 0.00% | – |
| Q1 2017 | $39,000 | +14.7% | 1,570 | 0.0% | 0.00% | – |
| Q4 2016 | $34,000 | +21.4% | 1,570 | +16.6% | 0.00% | – |
| Q3 2016 | $28,000 | +27.3% | 1,346 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | -24.1% | 1,346 | 0.0% | 0.00% | – |
| Q1 2016 | $29,000 | -29.3% | 1,346 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $41,000 | +215.4% | 1,346 | +124.7% | 0.00% | – |
| Q3 2015 | $13,000 | – | 599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |